For Immediate Release
Wednesday, October 3, 2018
10:00 a.m. U.S. Pacific Time
Tuesday through Saturday, Oct. 16-20, 2018
American Society of Human Genetics 2018 Annual Meeting
San Diego Convention Center
111 West Harbor Drive, San Diego, CA 92101
Invited and platform sessions and other presentations of the latest research in cancer genetics.
Wednesday, Oct. 17, 2018
9:00-10:00 a.m., Room 6A, Upper Level
Session: Clonal Mosaicism in Cancer, Alzheimer’s Disease, and Healthy Tissue
10:30 a.m.-12:30 p.m., Ballroom 20D, Upper Level
Session: Large Scale Functional Annotation of Variants of Uncertain Significance
10:30-11 a.m., Ballroom 20A, Upper Level
Session: Understanding Tumor Heterogeneity from Single Cell Sequencing of Genomes, Transcriptomes, and Epigenomes
10:30-11:00 a.m., Ballroom 20BC, Upper Level
Presentation: Use of the polygenic risk score as part of breast cancer risk assessment in the WISDOM Risk Thresholds Trial.
E. Ziv, University of California, San Francisco
4:15-5:45 p.m., Ballroom 20BC, Upper Level
Session: Integrated Variant Analysis in Cancer Genomics
Thursday, Oct. 18, 2018
9:00-10:30 a.m., Room 6C, Upper Level
Presentation: Insights into the patterns of somatic mutation accumulation in human cancer.
K. Akdemir, MD Anderson Cancer Center, et al
10:00-10:15 a.m., Room 6E, Upper Level
Presentation: Explaining gene expression: Massively parallel in-silico testing of gene expression regulators reveals large scale patterns of shared and divergent regulation across cancers and tissues.
L. Erdman, Hospital for Sick Children, et al
Friday, Oct. 19, 2018
9:00-10:00 a.m., Ballroom 2A, Upper Level
Session: Mutational Processes in Cancer
9:00-10:00 a.m., Ballroom 2BC, Upper Level
Session: Genetics of Cancer Therapy Response and Resistance
12:00-12:30 p.m., Room 6A, Upper Level
Presentation: Epigenetic age and epiallele shifts in cancer, forensics, and astronauts.
C. Mason, Weill Cornell Medical College
12:00-12:30 p.m., Room 6B, Upper Level
Presentation: Clinical insights from phosphoproteomic and proteogenomic analysis of pathways in cancer.
K. Rodland, Pacific Northwest National Lab, Oregon Health & Science University
Saturday, Oct. 20, 2018
8:30-9:30 a.m., Ballroom 20A, Upper Level
Session: Transcriptome Alterations in Cancer
8:30-9:30 a.m., Room 6D, Upper Level
Session: Cancer Genomic Testing: Uncertainty and Decision Making
8:30-9:30 a.m., Room 6E, Upper Level
Session: Leveraging the Cancer Genome Atlas
12:20-12:35 p.m., Hall C, Ground Level
Plenary Presentation: Comprehensive analysis of alternative splicing across tumors from 8,705 patients.
K. Lehmann, ETH Zurich, Switzerland, et al
Ongoing: Posters Open for Viewing, Exhibit Hall, Halls D-H, Ground Level
Topic: Cancer Genetics, Posters 655-975
About the American Society of Human Genetics (ASHG)
Founded in 1948, the American Society of Human Genetics is the primary professional membership organization for human genetics specialists worldwide. Its nearly 8,000 members include researchers, academicians, clinicians, laboratory practice professionals, genetic counselors, nurses, and others with an interest in human genetics. The Society serves scientists, health professionals, and the public by providing forums to: (1) share research results through the ASHG Annual Meeting and in The American Journal of Human Genetics; (2) advance genetic research by advocating for research support; (3) educate current and future genetics professionals, health care providers, advocates, policymakers, educators, students, and the public about all aspects of human genetics; and (4) promote genetic services and support responsible social and scientific policies. For more information, visit: http://www.ashg.org.